1. MicroRNA-203 inhibits invasion and induces apoptosis of laryngeal cancer cells via targeting LASP1
- Author
-
J, Tan, Y-Y, Jing, L, Han, H-W, Zheng, J-X, Shen, L-H, Zhang, and L-S, Yu
- Subjects
Binding Sites ,Apoptosis ,LIM Domain Proteins ,Gene Expression Regulation, Neoplastic ,Cytoskeletal Proteins ,MicroRNAs ,Cell Movement ,Cell Line, Tumor ,Humans ,Neoplasm Invasiveness ,Promoter Regions, Genetic ,Laryngeal Neoplasms ,Adaptor Proteins, Signal Transducing ,Signal Transduction - Abstract
To explore the role of microRNA-203 in laryngeal cancer and its underlying mechanism in regulating cell invasion and apoptosis.MicroRNA-203 expression in laryngeal cancer tissues and paracancerous tissues was detected by quantitative real time-polymerase chain reaction (qRT-PCR). The regulatory effects of microRNA-203 on the invasion and apoptosis of laryngeal cancer cells were detected by transwell assay and flow cytometry, respectively. Dual-Luciferase reporter gene assay was performed to access the binding condition of microRNA-203 and LASP1. Both mRNA and protein levels of LASP1 in laryngeal cancer cells were detected after transfection with microRNA-203 mimic or microRNA-203 inhibitor by qRT-PCR and Western blot, respectively. Rescue experiments were finally performed to detect whether microRNA-203 regulates laryngeal cancer development via targeting LASP1.MicroRNA-203 was lowly expressed in laryngeal cancer tissues and cell lines. MicroRNA-203 knockdown in Hep-2 cells can promote the invasion and inhibit the apoptosis of laryngeal cancer cells. Subsequently, LASP1 was predicted to be the target gene of microRNA-203, which was further verified by the Dual-Luciferase reporter gene assay. LASP1 expression was negatively regulated by microRNA-203. Furthermore, rescue experiments showed that the regulatory effects of microRNA-203 on the invasion and apoptosis of laryngeal cancer cells were reversed by LASP1.We showed that lowly expressed microRNA-203 could promote the invasion and inhibit apoptosis of laryngeal cancer cells via inhibiting LASP1.
- Published
- 2018